How do heart disease and stroke become risk factors for Alzheimer's disease?

Neurological Research

Volumn 28, Issue 6, 2006, Pages 637-644

  De La Torre, Jack C ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid beta; Brain hypoperfusion; Heart disease; Neuronal energy; Risk factor; Stroke

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; BRAIN PERFUSION; CAROTID ARTERY DISEASE; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; NEUROPATHOLOGY; REVIEW; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; WHITE COAT HYPERTENSION;

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; ENERGY METABOLISM; HEART DISEASES; HUMANS; RISK FACTORS;

EID: 33748951370     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X130362     Document Type: Review

References (86)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Bureau of Disease Study. Lancet 1997; 349: 1269-1276
2. Ebbell B. The Papyrus Ebers. The Greatest Egyptian Medical Document, Copenhagen: Levin & Munksgaard, 1937
3. de la Torre JC. Hemodynamics of deformed microvessels in Alzheimer's disease brain. Ann NY Acad Sci 1997; 826: 75-91
4. Young R, Worthley LI. Current concepts in the management of heart failure. Crit Care Resusc 2004; 6: 31-53
5. Newman MF, Croughwell ND, Blumenthal JA, et al. Effect of aging on cerebral autoregulation during cardiopulmonary bypass. Association with postoperative cognitive dysfunction. Circulation 1994; 90 (Pt. 2): II243-II249
6. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol 2004; 3: 184-190
7. de la Torre JC. Alzheimer's disease as a vascular disorder: Nosological evidence. Stroke 2002; 33: 1152-1162
8. Lee TA, Wolozin B, Weiss KB, et al. Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimer Dis 2005; 7: 319-324
9. Degirmenci B, Durak H, Hazan E, et al. The effect of coronary artery bypass surgery on brain perfusion. J Nucl Med 1998; 39: 587-91
10. Gunaydin B, Babacan A. Cerebral hypoperfusion after cardiac surgery and anesthetic strategies: A comparative study with high dose fentanyl and barbiturate anesthesia. Ann Thorac Cardiovasc Surg 1998; 4: 12-17
11. Ott A, Breteler MM, de Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997; 28: 316-321
12. Forti P, Maioli F, Pisacane N, et al. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. Neurol Res 2006; in press
13. Gomez CR, McLaughlin JR, Njemanze PC, et al. Effect of cardiac dysfunction upon diastolic cerebral blood flow. Angiology 1992; 43: 625-630
14. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993; 341: 1317-1322
15. Corder E, Ervin JF, Lockhart E, et al. Cardiovascular damage in Alzheimer disease: Autopsy findings from the Bryan ADRC. J Biomed Biotechnol 2005; 2005: 189-197
16. Pasquier F, Henon H, Leys D. [Risk factors and mechanisms of post-stroke dementia]. Rev Neurol (Paris) 1999; 155: 749-753
17. Boudoulas KD, Sparks EA, Rittgers SE, et al. Factors determining left atrial kinetic energy in patients with chronic mitral valve disease. Herz 2003; 28: 437-444
18. Sparks DL, Hunsaker J, Scheff S, et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease, Neurobiol Aging 1990; 11: 601-607
19. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-1851
20. Elias MF, Wolf PA, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 1993; 138: 353-364
21. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 49-55
22. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145
23. Qiu C, von Strauss E, Fastbom J, et al. Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Arch Neurol 2003; 60: 223-228
24. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzhejmer's disease in later life: Longitudinal, population based study. BMJ 2001; 322: 1447-1451
25. Wu C, Zhou D, Wen C, et al. Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 2003; 72: 1125-1133
26. Guo Z, Fratiglioni L, Zhu L, et al. Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Arch Neurol 1999; 56: 991-996
27. Khachaturian AS, Zandi PP, Lyketsos CG, et al. Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Arch Neurol 2006; 63: 686-692
28. Mielke MM, Zandi PP, Blennow K, et al. Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life. Alzheimer Dis Assoc Disord 2006; 20: 30-36
29. McCabe RD, Bakarich MA, Srivastava K, et al. Potassium inhibits free radical formation. Hypertension 1994; 24: 77-82
30. Young DB, Ma G. Vascular protective effects of potassium. Semin Nephrol 1999; 19: 477-486
31. Chen WT, Brace RA, Scott JB, et al. The mechanism of the vasodilator action of potassium. Proc Soc Exp Biol 1972; 140: 820-824
32. Ramchandra R, Barrett CJ, Malpas SC. Nitric oxide and sympathetic nerve activity in the control of blood pressure. Clin Exp Pharmacol Physiol 2005; 32: 440-446
33. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: Role of constitutive nitric oxide. Brain Res Rev 2000; 34: 119-136
34. Pak T, Cadet P, Mantione KJ, et al. Morphine via nitric oxide modulates beta-amyloid metabolism: A novel protective mechanism for Alzheimer's disease. Med Sci Monit 2005; 11: BR357-BR366
35. Franks PW. White-coat hypertension and risk of stroke: Do the data really tell us what we need to know? Hypertension 2005; 45: 183-184
36. Goodlin SJ. Heart failure in the elderly. Expert Rev Cardiovasc Ther 2005; 3: 99-106
37. Zuccala G, Gattel C, Manes-Gravina E, et al. Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 63: 509-512
38. Polidori MC, Marvardi M, Cherubini A, et al. Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer's dementia. Aging (Milano) 2001; 13: 231-239
39. Polidori CM, Mariani E, Mecocci P. Congestive heart failure and Alzheimer's disease. Neurol Res 2006; in press
40. Rosemberg GA, Haaland RY. Cardiogenic dementia. Lancet 1981; ii: 1171
41. Alves TC, Rays J, Fraguas R, Jr, et al. Localized cerebral blood flow reductions in patients with heart failure: A study using 99mTc-HMPAO SPECT. J Neuroimaging 2005; 15: 150-156
42. Alves TC, Busatto GF. Cerebral blood flow reductions, heart failure and Alzheimer's disease. Neurol Res 2006; in press
43. Koide H, Kobayashi S, Kitani M, et al. Improvement of cerebral blood flow and cognitive function following pacemaker implantation in patients with bradycardia. Gerontology 1994; 40: 79-85
44. Zuccala G, Onder G, Marzetti E, et al; GIFA Study Group. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 2005; 26: 226-233
45. Breteler MB, Claus J, Grobbee D, et al. Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study. BMJ 1994; 308: 1604-1608
46. Sabbagh M, Zahiri HR, Ceimo J, et al. Is there a characteristic lipid profile in Alzheimer's disease? J Alzheimers Dis 2004; 6: 585-589
47. Patatanian E, Gales MA. The future of statins: Alzheimer's disease? Consult Pharm 2005; 20: 663-673
48. Miida T, Takahashi A, Tanabe N, et al. Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression? Curr Opin Lipidol 2005; 16: 619-623
49. Sjogren M, Blennow K. The link between cholesterol and Alzheimer's disease. World J Biol Psychiatry 2005; 6: 85-97
50. Roher AE, Esh C, Kokjohn TA, et al. Circle of Willis Atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003; 23: 2055-2062
51. Roher AE, Esh C, Rahman A, et al. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623-2627
52. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005; 64: 494-500
53. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997; 349: 151-154
54. Napoli C, Palinski W. Neurodegenerative diseases: Insights into pathogenic mechanisms from atherosclerosis. Neurobiol Aging 2005; 26: 293-302
55. Cacabelos R, Fernandez-Novoa L, Corzo L, et al. Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component. Neurol Res 2004; 26: 459-480
56. Gusti SI, Coteanu MI, Gusti AS. Study of the cerebral vascular Doppler velocimetry and EEG in a group of 18 cases of Alzheimer's disease. Rom J Physiol 2004; 41: 91-97
57. Kalback W, Esh C, Castano EM, et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 2004; 26: 525-539
58. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging 2000; 903: 424-436
59. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222
60. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999; 67: 66-72
61. Ohyama M, Mizushige K, Ohyama H, et al. Carotid turbulent flow observed by convergent color Doppler flowmetry in silent cerebral infarction. Int J Cardiovasc Imaging 2002; 18: 119-124
62. Nakane H, Ibayashi S, Fujii K, et al. Cerebral blood flow and metabolism in patients with silent brain infarction: Occult misery perfusion in the cerebral cortex. J Neurol Neurosurg Psychiatry 1998; 65: 317-321
63. Yao H, Fujishima M. Cerebral blood flow and metabolism in silent brain infarction and related cerebrovascular disorders. Ann Med 2001; 33: 98-102
64. Cupini LM, Diomedi M, Placidi F, et al. Cerebrovascular reactivity and subcortical infarctions. Arch Neurol 2001; 58: 577-578
65. Morris JC. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics 2005; Suppl.: 9-14
66. Albers GW, Caplan LR, Easton JD, et al. Transient ischemic attack-proposal for a new definition. N Engl J Med 2002; 347: 1713-1716
67. Rao R, Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease, a comparison with healthy community residents. Stroke 1999; 30: 2167-2173
68. Lopez Gaston JI, Martin J, et al. [The evaluation of cognitive deterioration in transient ischemic attacks]. Neurologia 1993; 8: 171-176
69. Bakker FC, Klijn CJ, van der Grond J, et al. Cognition and quality of life in patients with carotid artery occlusion: A follow-up study. Neurology 2004; 62: 2230-2235
70. Ruitenberg A, den Heiker T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study. Ann Neurol 2005; 57: 789-794
71. de la Torre JC. Critical threshold cerebral hypoperfusion causes Alzheimer's disease. Acta Neuropathol 1999; 98: 1-8
72. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998; 50: 1563-1571
73. Meyer JS, Rauch G, Rauch RA, et al. Risk factors for cerebral hypoperfusion, mild cognitive impairment and dementia. Neurobiol Aging 2000; 21: 161-169
74. Akkawi NM, Borroni B, Agosti C, et al. Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: Evidence from an ultrasonographic study. J Neurol 2005; 252: 559-563
75. de la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 1993; 15: 146-153
76. de la Torre JC, Fortin, T, Park G, et al. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992; 582: 186-195
77. de la Torre JC, Fortin T, Park G, et al. Aged but not young rats develop metabolic, memory deficits after chronic brain ischemia. Neurol Res 1992; 14: 177-180
78. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004; 5: 347-360
79. Borroni B, Anchisi D, Paghera B, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006; 27: 24-31
80. Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol 2006; 44: 1-11
81. Lee HG, Petersen RB, Zhu X, et al. Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathol 2003; 13: 630-638
82. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990; 113: 27-47
83. Silverman DH, Phelps ME. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: Normal development, aging, dementia, and stroke. Mol Genet Metab 2001; 74: 128-138
84. Zhou W, Qingh H, Tong Y, et al. BACE1 gene expression and protein degradation. Ann NY Acad Sci 2004; 1035: 49-67
85. Fluhrer R, Capell A, Westmeyer G, et al. A non-amyloidogenic function of BACE-2 in the secretory pathway. J Neurochem 2002; 81: 1011-1020
86. de la Torre JC. Alzheimer's disease: How does it start? J Alzheimers Dis 2002; 4: 497-512